Predicting exacerbations in severe preschool wheezers

Michael Fayon1,2, Fabien Beaufils1,2

  • 1Centre de Recherche Cardio-thoracique de Bordeaux, INSERM U1045, University of Bordeaux, Bordeaux, France.

Pediatric Pulmonology
|October 25, 2024
PubMed

Insights

Evaluating preschool wheezing risk is now possible using clinical indices and telemonitoring. Identifying underlying causes like smoke exposure and immune responses is key, but disease-modifying treatments are still needed.

Area of Science:

  • Pediatric respiratory medicine
  • Immunology
  • Environmental health

Background:

  • Preschool wheezing is a common condition with significant health implications.
  • Current methods allow for risk evaluation at both population and individual levels.
  • Understanding the multifactorial nature of wheezing is crucial for effective management.

Purpose of the Study:

  • To discuss the utility of clinical markers for assessing preschool wheezing risk.
  • To highlight key underlying pathophysiological factors contributing to wheezing.
  • To identify the primary unmet need in managing this condition.

Main Methods:

  • Review of current clinical indices and telehome monitoring techniques.
  • Discussion of pathophysiological pathways including viral-immunological-allergic interactions.
  • Analysis of cellular changes in airway epithelium, mesenchyme, and smooth muscle.

Main Results:

  • Clinical indices, composite phenotyping/endotyping, and telehome monitoring offer valuable tools for risk assessment.
  • Underlying factors such as in utero smoke exposure, viral infections, and allergic responses play significant roles.
  • Airway cellular changes are integral to the development of preschool wheezing.

Conclusions:

  • Effective risk stratification for preschool wheezing is achievable with current tools.
  • A comprehensive understanding of contributing factors is essential for targeted interventions.
  • The development of disease-modifying interventions remains a critical unmet need for this age group.

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
234
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
361